Is a complete APMD research report available?

No complete published report is available for Apnimed, Inc. (APMD) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Apnimed, Inc. (APMD)

NASDAQ: APMD · Currency not recorded

25.0

+9.00 (+56.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-01 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first APMD analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1B
Revenue (ttm)	120.2M
Net income (ttm)	-31.8M
EPS (ttm)	-6.28
Shares out	40M
P/E (trailing)	3.7x
Volume	3,441,886

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 120.2M
Net income (ttm): -31.8M
EPS (ttm): -6.28
P/E (trailing): 3.7x
Market cap: 1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.5B	36.6x	5.7x	96.6%	+47.5%	-39.5%	Strong Buy
ARGX	argenx SE	53.6B	31.3x	10.1x	50.6%	+58.8%	+42.6%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All APMD indicators

Market & fundamental data

Available fields

136

Groups with data

Currency

USD

Showing 136 of 136 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001745648
Company name	Apnimed, Inc.
Country	United States
Country code	US
Employees	65
Employees Change	0%
Employees Change Percent	0
Enterprise value	$992.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-08-01
Industry	Biotechnology
IPO Date	2026-07-31
Last refreshed	2026-08-01
Market cap	$1B
Market cap category	Small-Cap
Price	$25
Rev Per Employee	1,848,461.54x
Sector	Healthcare
Sector PE	44.2
Sector PE Fwd	23.57
Sic	2834
Symbol	APMD
Website	https://apnimed.com/

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.18%
EV/EBIT	24.01x
EV/EBITDA	23.99x
EV/Sales	8.26x
FCF yield	-6.92%
P/E ratio	3.67x
P/S ratio	8.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.41%
EBITDA Margin	34.43%
Gross margin	93.73%
Gross Profit	$112.6M
Gross Profit Growth	11,161.3%
Net Income	$-31.8M
Net Income Growth Years	0%
Pretax Margin	32.46%
Profit Margin	-26.49%
Profit Per Employee	$-489,631
ROCE	108.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	0
Revenue Growth	11,915x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$79M
Cash	$46.9M
Current Assets	$78.2M
Current Liabilities	$41M
Debt	$39.3M
Debt EBITDA	$0.94
Equity	$-58.2M
Liabilities	$137.2M
Long Term Assets	$859,000
Long Term Liabilities	$96.2M
Net Cash	$7.5M
Net Cash By Market Cap	$0.75
Net Debt EBITDA	$-0.18
Tangible Book Value	$-304.1M
Tangible Book Value Per Share	$-53.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.91
Net Working Capital	$-9.5M
Quick ratio	1.17
Working Capital	$37.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-127.88%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	29.15
All Time High Change	-12.18%
All Time High Date	2026-07-31
All Time Low	16
All Time Low Change	48.5%
All Time Low Date	2026-07-29
High	29.15
High52	27.74
High52 Date	2026-07-31
High52ch	-9.88%
Low	16.12
Low52	16
Low52 Date	2026-07-30
Low52ch	56.25%
RSI	0
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	15.86x
Total Return	-127.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$41.3M
Operating margin	34.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,544,711%
Float Percent	86.36%
Net Borrowing	35,000,000
Shares Insiders	1.27%
Shares Out	39,999,640
Shares Qo Q	701.06%
Shares Yo Y	127.88%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-73.2M
Adjusted OCF	-73,227,000
Average Volume	833,980.67x
Bv Per Share	-53.95
Change	56.25%
Change From Open	13.64
Close	16
Days Gap	37.5
Depreciation Amortization	26,000
Dollar Volume	86,047,150
EBIT	$41.3M
EBITDA	$41.4M
EPS	$-6.28
F Score	0
FCF	$-69.2M
FCF EV Yield	-6.97x
FCF Per Share	$-1.73
Financing CF	76,180,000
Fiscal Year End	December
Founded	2,017
Ipr	56.25
Iprfo	13.64
Is Spac	No
Last Report Date	2026-03-31
Last Split Type	Never
Net CF	6,988,000
Open	22
Position In Range	68.15
Post Close	25
Postmarket Change Percent	-10.96
Postmarket Price	$22.26
Ppne	835,000
Price Date	2026-07-31
Price EBITDA	$24.18
Relative Volume	4.13x
Revenue	120,150,000x
SBC By Revenue	3.36x
Share Based Comp	4,035,000
Us State	MA
Views	734
Volume	3,441,886
Z Score	-2.03

Apnimed, Inc. (APMD)

Coverage state: Market snapshot only — no published research

Generate the first APMD analysis

Price

Financial snapshot

Fair-value bridge

Latest news · APMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All APMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on APMD

Frequently asked questions